Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that originate from specialized cells of the body’s neuroendocrine system. A hallmark of NETs is the ability to express and secrete various amines and peptide hormones, which leads to the development of various endocrine syndromes. Often, the severity of hormonal hyperproduction determines the quality of life and patient outcome. NETs can develop anywhere in the body, most occur in the gastro-entero-pancreatic system, lungs, and paraganglia. They can differ greatly in their natural course and ability to metastasize. Another important feature of NETs is that they are often very small, making them difficult to detect. The diagnostic workup focuses on NETs detecting as early as possible and assessing their malignant potential.
This Research Topic welcomes original research, including clinical, translational, as well as molecular studies, review articles, and clinical trials on a range of topics related to current and new diagnostic approaches for NETs. Potential topics include, but are not limited to:
- Molecular imaging (68Ga-DOTA-peptides, F18-dopamine, and etc),
- Endoscopic ultrasonography (in detecting pancreatic neuroendocrine tumors),
- MRI (for PitNET diagnosis and prognosis) or challenges in the morphological diagnosis of pituitary neuroendocrine tumors,
- Neuroendocrine tumors biomarkers and NETest.
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that originate from specialized cells of the body’s neuroendocrine system. A hallmark of NETs is the ability to express and secrete various amines and peptide hormones, which leads to the development of various endocrine syndromes. Often, the severity of hormonal hyperproduction determines the quality of life and patient outcome. NETs can develop anywhere in the body, most occur in the gastro-entero-pancreatic system, lungs, and paraganglia. They can differ greatly in their natural course and ability to metastasize. Another important feature of NETs is that they are often very small, making them difficult to detect. The diagnostic workup focuses on NETs detecting as early as possible and assessing their malignant potential.
This Research Topic welcomes original research, including clinical, translational, as well as molecular studies, review articles, and clinical trials on a range of topics related to current and new diagnostic approaches for NETs. Potential topics include, but are not limited to:
- Molecular imaging (68Ga-DOTA-peptides, F18-dopamine, and etc),
- Endoscopic ultrasonography (in detecting pancreatic neuroendocrine tumors),
- MRI (for PitNET diagnosis and prognosis) or challenges in the morphological diagnosis of pituitary neuroendocrine tumors,
- Neuroendocrine tumors biomarkers and NETest.
